| Disease | mental depression |
| Phenotype | |vascular disease |
| Sentences | 62 |
| PubMedID- 25653245 | Glucose levels may predict depression in patients with cardiovascular diseases. |
| PubMedID- 25633682 | Neuroimaging studies suggest that atrophy of temporal or frontal structures, white matter lesions in frontal lobe or subcortical systems, reduced activity in dorsolateral frontal cortex, or small vessel cerebrovascular disease may be associated with depression in ad. |
| PubMedID- 22260713 | depression is associated with cardiovascular disease. |
| PubMedID- 25237578 | Objectives: we investigated serum levels of 10 cytokines and their relationship with depression in patients with cardiovascular diseases as well as healthy subjects in northeast of iran. |
| PubMedID- 21122918 | Conclusions: late-life depression has been associated with vascular disease but previous studies examining vascular risk factors have been inconsistent. |
| PubMedID- 25439033 | Adjusted odds ratios for depression rose monotonically with number of cardiovascular disease (cvd) risk factor from 1.46 (95% ci, 1.18-1.75) for those with one risk factors to 4.36 (95% ci, 2.47-7.70) for those with five risk factors. |
| PubMedID- 20132412 | depression is associated with vascular disease, such as myocardial infarction and stroke. |
| PubMedID- 25640936 | A new role for nortriptyline in depression associated with vascular disease. |
| PubMedID- 24058602 | There is also evidence to suggest that routine depression screening in patients with cardiovascular disease may not lead to improvement in clinical outcomes [15,16]. |
| PubMedID- 23293051 | Treatment of depression in cardiovascular disease. |
| PubMedID- 20086253 | Further, low birth weight has been found to modify the association of diabetes or cardiovascular disease with depression in a sample of older adults (24). |
| PubMedID- 22174200 | Conclusion: in sle, depression is independently associated with vascular disease, along with physical factors. |
| PubMedID- 23388591 | [valdoxan (agomelatine) in the treatment of depression in patients with cerebrovascular diseases: the results of the russian multicenter naturalistic study "resonance"]. |
| PubMedID- 24931717 | Cardiovascular disease risk factors associated with depression among korean adults with coronary artery disease and cerebrovascular disease. |
| PubMedID- 25675558 | Objective: to explore the difference in the efficacy and effect mechanism of subcortical ischemic vascular disease (sivd) complicated with depression between acupuncture and medication. |
| PubMedID- 26278479 | In a recent meta-analysis of major depressive disorder (mdd) and hrv, kemp et al.2 reveal that unmedicated depression without cardiovascular disease (cvd) is associated with decreased vagal (parasympathetic) tone, as indexed by reduced hrv. |
| PubMedID- 24307378 | Nevertheless, depression in patients with cardiovascular disease is not only associated with clinical outcomes, but also with adherence and poorer health status and impairments to quality of life independent of disease severity [26]. |
| PubMedID- 20859545 | Absolute contraindications to β-blockers are severe or advanced bradycardia, conduction system disease (sinus node dysfunction and/or high-grade av block), asthma, peripheral vascular disease (pad) with rest ischemia, depression, and overt heart failure (hf). |
| PubMedID- 21118498 | The association between vascular disease with depression, apathy, anxiety and irritability remains although strength is reduced. |
| PubMedID- 24679672 | Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease. |
| PubMedID- 21779108 | Chronic inflammation may underlie many forms of depression associated with vascular disease and metabolic syndrome. |
| PubMedID- 23409901 | Association of posttraumatic stress disorder and depression with all-cause and cardiovascular disease mortality and hospitalization among hurricane katrina survivors with end-stage renal disease. |
| PubMedID- 24688991 | Rumsfeld and ho (2005) assert that: “the failure to recognize depression in patients with cardiovascular disease is a failure to provide the best care for our patients” (p. 252). |
| PubMedID- 24349610 | In fact, depression is often associated with cardiovascular disease, stroke, dementia, and alzheimer [53, 55, 56], and it is characterized by anticipated gene expression changes (e.g., downregulation of the brain derived neurotrophic factor (bdnf)), which usually occurs in the aged brain [57]. |
| PubMedID- 22849956 | Trial evidence has not suggested that treating depression decreases mortality in patients with existing cardiovascular disease,515253 but evidence from the current study of the increased risk associated with even low levels of psychological distress in the general population suggests that the overall picture may be more complex. |
| PubMedID- 24715877 | This stress paradigm has recently been applied to study the shared pathophysiology that links stress-related psychological disorders such as anxiety and depression with cardiovascular disease (carnevali et al., 2012b, 2013b; wood et al., 2012; sevoz-couche et al., 2013). |
| PubMedID- 23967272 | Our hypotheses are that somatic symptoms of depression are mainly associated with cardiovascular disease, cardiovascular risk factors, increased inflammation and vascular dysfunction, whereas cognitive symptoms are mainly associated with a medical history of depression and the distressed personality (type d) [14]. |
| PubMedID- 24039506 | How should we treat depression in patients with cardiovascular disease. |
| PubMedID- 24166703 | In adjusted analyses phobia comorbid with depression was associated with cerebrovascular disease (odds ratio (or) 1.61; 95 % confidence interval (ci) 1.04-2.50) as was panic disorder (or 2.89; 95 % ci 1.47-5.69). |
| PubMedID- 22783296 | This observation contributes to the hypothesis that depression is linked with cardiovascular disease through platelet dysregulation. |
| PubMedID- 23611535 | Persistence of subsyndromal residual symptoms after remission of major depression in patients without cardiovascular disease may condition maintenance of elevated platelet factor 4 and beta-thromboglobulin plasma levels. |
| PubMedID- 25044493 | Aims: symptoms of anxiety and depression often co-exist with cardiovascular disease, yet little is known about the prospective risk for heart failure (hf) in people with symptoms of depression and anxiety. |
| PubMedID- 21960687 | Aims: depression often coexists with cardiovascular disease, such as hypertension and heart failure, in which sympathetic hyperactivation is critically involved. |
| PubMedID- 21731754 | depression often coexists with cardiovascular disease, and nearly 7% of warfarin users are co-prescribed antidepressants [4]. |
| PubMedID- 22832857 | Vascular depression is associated with vascular disease, risk factors (e.g., diabetes mellitus, obesity) and late onset or change in the course of early-onset depression following the onset of vascular disease.126 the ‘vascular depression' hypothesis proposed by alexopoulos et al.126 suggests that characteristics of cerebrovascular disease and their risk factors are involved in the development of late-life depression. |
| PubMedID- 22016750 | In the second part, the authors present the available tests and questionnaires to assess depression and anxiety in patients with cardiovascular disease. |
| PubMedID- 25910599 | depression in cardiovascular disease: from awareness to action. |
| PubMedID- 22830072 | depression in patients with cardiovascular disease. |
| PubMedID- 23354730 | Conclusion: the treatment of depression in cardiovascular disease patients may therefore benefit from a psychological intervention focused on patients' illness representations, self-efficacy beliefs, and their perceived social support. |
| PubMedID- 21234098 | depression has been associated with increased cardiovascular disease risk, and a depression-related elevation of high sensitivity c-reactive protein (hs-crp) has been proposed as a possible mechanism. |
| PubMedID- 20690128 | Cardiovascular disease and death associated with depression and antidepressants in the melbourne longitudinal studies on healthy ageing (melsha). |
| PubMedID- 22952536 | Considering the high prevalence of depression and anxiety in patients with cardio-vascular diseases, which may have negative effects on the course and prognosis of the disease and may increase the mortality and morbidity, it is necessary to screen the psychological disorders in patients with cardio-vascular diseases and improve their cardio-vascular health and quality of life as mush as possible. |
| PubMedID- 24206945 | This study showed distinctive patterns of motor cortex excitability between late-onset depression with subcortical vascular disease and early-onset recurrent drug resistant md. |
| PubMedID- 20153471 | It is also possible that the underlying pathology linking depression with cardiovascular disease (cvd) is specific to the coronary vessels. |
| PubMedID- 24313242 | Trauma exposure predicts alcohol, nicotine, and drug problems beyond the contribution of ptsd and depression in patients with cardiovascular disease: data from the heart and soul study. |
| PubMedID- 24769297 | Background: dietary habits and depression are associated with cardiovascular disease risk. |
| PubMedID- 23631737 | For example, depression is significantly associated with cardiovascular disease, diabetes, obesity, asthma, epilepsy, and cancer and with health risk behaviors such as alcohol abuse [8-11]. |
| PubMedID- 25667165 | depression leads to incident vascular disease: evidence for the relevance to primary care. |
| PubMedID- 24649359 | Therefore, other important instruments which are often used in the clinical practice to evaluate depression in patients with cardiovascular disease may have been left out. |
| PubMedID- 23630509 | The bdi is a reliable and well-validated measure of depressive symptomatology (beck et al., 1988), and is a widely used self-report measure of depression in patients with cardiovascular disease. |
Page: 1 2